Absci Corp (ABSI)

$2.95 -0.04 (-1.34%)
Market Cap 457.53M
Revenue (ttm) 2.80M
Net Income (ttm) -115.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,113.57%
Debt to Equity Ratio 0.00
Volume 3,385,900
Avg Vol 3,603,220
Day's Range N/A - N/A
Shares Out 153.02M
Stochastic %K 49%
Beta 2.00
Analysts Strong Sell
Price Target $8.03

Company Profile

Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration...

Industry: Biotechnology
Sector: Healthcare
Phone: 360 949 1041
Address:
18105 SE Mill Plain Boulevard, Vancouver, United States
Floridaorange
Floridaorange Apr. 8 at 7:43 PM
$RXRX $RXRX $ABSI $SDGR $RLAY RXRX only company here with full closed-loop (data + wet lab + AI). Others are point solutions. Market not pricing that yet. ✅
2 · Reply
BioHunter1
BioHunter1 Apr. 8 at 6:58 PM
$ABSI Time for me to get out! 3 years of ups and downs, green and red is enough… GL
0 · Reply
BioHunter1
BioHunter1 Apr. 8 at 5:05 PM
$ABSI The SP loves being below $3 for some reason
0 · Reply
flam70
flam70 Apr. 7 at 5:37 PM
$ABSI $MANE mane has 2.3b market cap. Absci 450m
0 · Reply
TT_
TT_ Apr. 6 at 11:34 PM
$ABSI I literally don’t understand this price action. Someone please tell me before I lose my mind. If there’s no progress by June im selling my 68k shares
1 · Reply
AWetBlanket
AWetBlanket Apr. 6 at 8:18 PM
$ABSI Witness me bloodbag!
0 · Reply
BioHunter1
BioHunter1 Apr. 6 at 7:18 PM
$ABSI 1M share were bought at 12:20 followed by a 124K sold, followed by 35K, then 47K & so on…..
0 · Reply
BioHunter1
BioHunter1 Apr. 6 at 4:57 PM
$ABSI Big honchos swinging it on daily basis. We’re talking about 100s of thousands of shares at a time. Meanwhile we’re in the back seat watching, waiting and hopefully enjoying the ride…
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Apr. 4 at 7:10 PM
$MRNA $RLAY $RXRX $ABSI $SPY
2 · Reply
JennyRowes
JennyRowes Apr. 4 at 3:36 PM
$ABSI $ABCL $RXRX $GENB absi -15% ytd, 30% short abcl +3% ytd, 22% short rxrx -26% ytd, 35% short genb +9% ytd ??? short
0 · Reply
Latest News on ABSI
Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference

Apr 8, 2026, 8:00 AM EDT - 1 day ago

Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference

Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results

Mar 24, 2026, 4:05 PM EDT - 16 days ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Mar 6, 2026, 4:05 PM EST - 4 weeks ago

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer

Mar 3, 2026, 8:00 AM EST - 5 weeks ago

Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer

Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026

Feb 24, 2026, 8:00 AM EST - 6 weeks ago

Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026

Absci to Participate in Upcoming Investor Conferences

Feb 17, 2026, 8:00 AM EST - 7 weeks ago

Absci to Participate in Upcoming Investor Conferences

Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 16, 2025, 8:00 AM EST - 4 months ago

Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization

Dec 11, 2025, 8:00 AM EST - 4 months ago

Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization

Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research

Dec 10, 2025, 8:00 AM EST - 4 months ago

Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research

Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia

Dec 4, 2025, 8:00 AM EST - 4 months ago

Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia

Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results

Nov 12, 2025, 4:05 PM EST - 5 months ago

Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results

Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025

Oct 29, 2025, 4:05 PM EDT - 5 months ago

Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

Oct 15, 2025, 8:00 AM EDT - 6 months ago

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

Absci Boosts AI-Powered Drug Discovery With Oracle And AMD Collaboration

Sep 11, 2025, 12:10 PM EDT - 7 months ago

Absci Boosts AI-Powered Drug Discovery With Oracle And AMD Collaboration

AMD ORCL

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Sep 11, 2025, 8:00 AM EDT - 7 months ago

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

Aug 25, 2025, 4:05 PM EDT - 8 months ago

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

Aug 12, 2025, 4:05 PM EDT - 8 months ago

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Aug 7, 2025, 2:00 AM EDT - 8 months ago

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

Jul 30, 2025, 4:05 PM EDT - 9 months ago

Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

Intel, Absci, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Jul 25, 2025, 8:34 AM EDT - 9 months ago

Intel, Absci, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session

ASTS INTC

Absci Announces Pricing of Public Offering of Common Stock

Jul 24, 2025, 8:45 PM EDT - 9 months ago

Absci Announces Pricing of Public Offering of Common Stock

Absci Announces Proposed Public Offering of Common Stock

Jul 24, 2025, 4:54 PM EDT - 9 months ago

Absci Announces Proposed Public Offering of Common Stock

Absci Appoints Biopharma Leader Mary Szela to Board of Directors

Jul 7, 2025, 8:00 AM EDT - 9 months ago

Absci Appoints Biopharma Leader Mary Szela to Board of Directors

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

May 13, 2025, 4:05 PM EDT - 11 months ago

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

May 13, 2025, 4:01 PM EDT - 11 months ago

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

Apr 14, 2025, 4:05 PM EDT - 1 year ago

Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Mar 19, 2025, 8:15 AM EDT - 1 year ago

Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

HQY TNXP

Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results

Mar 18, 2025, 4:05 PM EDT - 1 year ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

Mar 4, 2025, 4:05 PM EST - 1 year ago

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

Mar 4, 2025, 8:00 AM EST - 1 year ago

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 18, 2025, 8:00 AM EST - 1 year ago

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside

Jan 22, 2025, 1:22 PM EST - 1 year ago

Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside

AMD

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Jan 22, 2025, 8:00 AM EST - 1 year ago

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Jan 10, 2025, 7:30 AM EST - 1 year ago

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

Jan 8, 2025, 7:00 AM EST - 1 year ago

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

Jan 6, 2025, 8:00 AM EST - 1 year ago

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

Nov 12, 2024, 7:30 AM EST - 1 year ago

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

Absci to Host R&D Day on December 12, 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Absci to Host R&D Day on December 12, 2024

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

Aug 14, 2024, 4:01 PM EDT - 1 year ago

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI

Aug 12, 2024, 8:00 AM EDT - 1 year ago

Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI

Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024

Jul 10, 2024, 8:00 AM EDT - 1 year ago

Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

May 28, 2024, 8:00 AM EDT - 2 years ago

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results

May 14, 2024, 7:30 AM EDT - 2 years ago

Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results

Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results

Mar 21, 2024, 7:30 AM EDT - 2 years ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results

Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

Mar 1, 2024, 4:01 PM EST - 2 years ago

Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI

Feb 21, 2024, 7:30 AM EST - 2 years ago

Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI

Absci Appoints Professor Sir Mene Pangalos to its Board of Directors

Jan 10, 2024, 7:30 AM EST - 2 years ago

Absci Appoints Professor Sir Mene Pangalos to its Board of Directors

Absci to Participate in the 26th Annual Needham Growth Conference

Jan 3, 2024, 8:00 AM EST - 2 years ago

Absci to Participate in the 26th Annual Needham Growth Conference

Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Dec 28, 2023, 8:00 AM EST - 2 years ago

Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Floridaorange
Floridaorange Apr. 8 at 7:43 PM
$RXRX $RXRX $ABSI $SDGR $RLAY RXRX only company here with full closed-loop (data + wet lab + AI). Others are point solutions. Market not pricing that yet. ✅
2 · Reply
BioHunter1
BioHunter1 Apr. 8 at 6:58 PM
$ABSI Time for me to get out! 3 years of ups and downs, green and red is enough… GL
0 · Reply
BioHunter1
BioHunter1 Apr. 8 at 5:05 PM
$ABSI The SP loves being below $3 for some reason
0 · Reply
flam70
flam70 Apr. 7 at 5:37 PM
$ABSI $MANE mane has 2.3b market cap. Absci 450m
0 · Reply
TT_
TT_ Apr. 6 at 11:34 PM
$ABSI I literally don’t understand this price action. Someone please tell me before I lose my mind. If there’s no progress by June im selling my 68k shares
1 · Reply
AWetBlanket
AWetBlanket Apr. 6 at 8:18 PM
$ABSI Witness me bloodbag!
0 · Reply
BioHunter1
BioHunter1 Apr. 6 at 7:18 PM
$ABSI 1M share were bought at 12:20 followed by a 124K sold, followed by 35K, then 47K & so on…..
0 · Reply
BioHunter1
BioHunter1 Apr. 6 at 4:57 PM
$ABSI Big honchos swinging it on daily basis. We’re talking about 100s of thousands of shares at a time. Meanwhile we’re in the back seat watching, waiting and hopefully enjoying the ride…
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Apr. 4 at 7:10 PM
$MRNA $RLAY $RXRX $ABSI $SPY
2 · Reply
JennyRowes
JennyRowes Apr. 4 at 3:36 PM
$ABSI $ABCL $RXRX $GENB absi -15% ytd, 30% short abcl +3% ytd, 22% short rxrx -26% ytd, 35% short genb +9% ytd ??? short
0 · Reply
musky54
musky54 Apr. 4 at 1:40 AM
$ABSI https://youtu.be/3IBBmIwrFmc?si=8Aj6uKpIlUeck1hG
0 · Reply
BioHunter1
BioHunter1 Apr. 2 at 5:47 PM
$CYDY $NWBO $ABSI Thank Goodness it will be a long weekend so we don’t have to see or deal with all this Crap. It’s the STUCK not STOCK markets anymore!!!
0 · Reply
BioHunter1
BioHunter1 Apr. 2 at 5:04 PM
$ABSI I honestly thought we broke through $3.07 and won’t go back below $3… What a joke
0 · Reply
DavyDaveCharts
DavyDaveCharts Apr. 1 at 10:02 PM
$ABSI nascent break out. Weekly. Momentum to the upside on MACD on the verge of a cross over. looking at 4.17 and 5.20 draw on liquidity.
0 · Reply
BenGang
BenGang Apr. 1 at 7:58 PM
$CSTM $BZAI $CYCN $SNDL $ABSI
0 · Reply
flam70
flam70 Apr. 1 at 2:35 AM
$ABSI Jones reiterated $9 price targe
0 · Reply
BioHunter1
BioHunter1 Mar. 31 at 8:15 PM
$ABSI yeah. Let’s demolish that $3.07 and keep going.
0 · Reply
anachartanalyst
anachartanalyst Mar. 30 at 11:01 AM
$ABSI https://anachart.com/wp-content/uploads/ana_temp/1774868470_soc-img.jpg
0 · Reply
LabPsycho
LabPsycho Mar. 30 at 12:21 AM
$ABSI I would be interested in opinions on ABSI vs QTTB.
0 · Reply
MaxPain_Trader
MaxPain_Trader Mar. 27 at 6:33 PM
$ABSI wow! Thanks for the dip
0 · Reply
JennyRowes
JennyRowes Mar. 25 at 4:54 PM
$ABSI does anyone else feel like this suddenly changed from a AI story to a single asset biotech? why invest in an AI platform if your only priority is ABSI201?
4 · Reply
BioHunter1
BioHunter1 Mar. 25 at 2:13 PM
$ABSI Exactly how it works. An early Pump followed by a Pump. Leopard don’t change their spots…
0 · Reply